Values as of: 2025-02-10
ETF | Others |
Last Closing
USD 3.57Change
+0.03 (+0.85)%Market Cap
USD 0.45BVolume
7.60MAnalyst Target
N/AVerdict
Verdict
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| SOJE | Southern Company (The) Series .. |
+0.03 (+0.16%) |
USD 65.72B |
| JEPI | JPMorgan Equity Premium Income.. |
+0.30 (+0.51%) |
USD 38.71B |
| DFAC | Dimensional U.S. Core Equity 2.. |
+0.18 (+0.51%) |
USD 33.57B |
| SGOV | iShares® 0-3 Month Treasury B.. |
+0.02 (+0.02%) |
USD 32.29B |
| JPST | JPMorgan Ultra-Short Income ET.. |
+0.02 (+0.04%) |
USD 28.80B |
| DTB | DTE Energy Company 2020 Series |
+0.11 (+0.59%) |
USD 26.58B |
| JAAA | Janus Detroit Street Trust - J.. |
+0.01 (+0.02%) |
USD 19.74B |
| GBTC | Grayscale Bitcoin Trust (BTC) |
+1.24 (+1.63%) |
USD 19.50B |
| AVUV | Avantis® U.S. Small Cap Value.. |
+0.32 (+0.33%) |
USD 16.10B |
| CGDV | Capital Group Dividend Value E.. |
+0.22 (+0.60%) |
USD 13.61B |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| YOLO | AdvisorShares Pure Cannab.. | 35.05 % | 0.00 % |
-0.03 (0%) |
USD 0.03B |
| BUDX | 23.56 % | 0.00 % |
N/A |
N/A |
| Market Performance vs. Industry/Classification (Others) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -6.30% | 4% | F | 10% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -6.30% | 4% | F | 10% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -59.57% | 1% | F | 2% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -59.57% | 1% | F | 2% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | N/A | N/A | N/A | N/A | N/A | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | -23.79% | 1% | F | 2% | F | ||
| Dividend Return | -23.79% | 1% | F | 2% | F | ||
| Total Return | N/A | N/A | N/A | N/A | N/A | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 41.81% | 5% | F | 23% | F | ||
| Risk Adjusted Return | -56.89% | 4% | F | 3% | F | ||
| Market Capitalization | 0.45B | 82% | B | 47% | F | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
